Intranasal immunization with serum opacity factor (SOF) of Streptococcus pyogenes fails to protect mice against lethal mucosal challenge with a heterologous strain

Vaccine

Volumn 24, Issue 9, 2006, Pages 1446-1450

  Schulze, Kai ^a   Medina, Eva ^a   Guzmán, Carlos A ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Mucosal delivery; SfbI; SOF; Streptococcus pyogenes; Vaccine

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; FIBRONECTIN BINDING PROTEIN; SERUM OPACITY FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; EXPERIMENTAL INFECTION; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; VACCINE PRODUCTION;

ADHESINS, BACTERIAL; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; CELLS, CULTURED; DRUG THERAPY, COMBINATION; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PEPTIDE HYDROLASES; SPECIES SPECIFICITY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; T-LYMPHOCYTES; VACCINES, SYNTHETIC;

EID: 32344435599     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.06.039     Document Type: Article

References (34)

1. A.L. Bisno Group A streptococcal infections and acute rheumatic fever N Engl J Med 325 1991 783 793
2. A.L. Bisno, and D.L. Stevens Streptococcal infections of skin and soft tissues N Engl J Med 334 4 1996 Jan 25 240 246
3. M.W. Cunningham Pathogenesis of Group A streptococcal infections Clin Microbiol Rev 13 3 2000 470 511
4. C.L. Streeton, J.N. Hanna, R.D. Messer, and A. Merianos An epidemic of acute post-streptococcal glomerulonephritis among aboriginal children J Paediatr Child Health 31 3 1995 245 248
5. J.R. Carapetis, D.R. Wolff, and B.J. Currie Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory Med J Aust 164 3 1996 146 149
6. B.J. Currie, and J.R. Carapetis Skin infections and infestations in aboriginal communities in northern Australia Australasian J. Dermatol. 41 3 2000 139 143
7. J.B. Dale, P.P. Cleary, V.A. Fischetti, D.L. Kasper, J.M. Musser, and J.B. Zabriskie Group A and group B streptococcal vaccine development. A round table presentation Adv Exp Med Biol 418 1997 863 868
8. E.R. Brandt, T. Teh, W.A. Relf, R.I. Hobb, and M.F. Good Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of Group A Streptococci Infect Immun 68 12 2000 6587 6594
9. C. Olive, T. Clair, P. Yarwood, and M.F. Good Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope Vaccine 20 21/22 2002 2816 2825
10. H.S. Courtney, J.B. Dale, and D.I. Hasty Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp-2 tissue culture cells Infect Immun 64 7 1996 2415 2419
11. E. Hanski, and M. Caparon Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes Proc Natl Acad Sci USA 89 13 1992 6172 6176
12. E. Hanski, J. Jaffe, and V. Ozeri Proteins F1 and F2 of Streptococcus pyogenes. Properties of fibronectin binding Adv Exp Med Biol 408 1996 141 150
13. B. Kreikemeyer, S.R. Talay, and G.S. Chhatwal Characterization of a novel fibronectin-binding surface protein in group A streptococci Mol Microbiol 17 1 1995 137 145
14. C.L. Rocha, and V.A. Fischetti Identification and characterization of a novel fibronectin-binding protein on the surface of group A streptococci Infect Immun 67 6 1999 2720 2728
15. S.R. Talay, P. Valentin Weigand, P.G. Jerlstrom, K.N. Timmis, and G.S. Chhatwal Fibronectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells Infect Immun 60 9 1992 3837 3844
16. G. Molinari, S.R. Talay, P. Valentin Weigand, M. Rohde, and G.S. Chhatwal The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells Infect Immun 65 4 1997 1357 1363
17. P.P. Cleary, Y.V. Matsuka, T. Huynh, H. Lam, and S.B. Olmsted Immunization with C5a peptidase from either group A or B streptococci enhances clearance of group A streptococci from intranasally infected mice Vaccine 22 31 2004 Oct 22 4332 4341
18. A. Shet, E. Kaplan, D. Johnson, and P.P. Cleary Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections Indian J Med Res 119 Suppl 2004 May 95 98
19. V. Kapur, J.T. Maffei, R.S. Greer, L.L. Li, G.J. Adams, and J.M. Musser Vaccination with streptococcal extracellular cysteine protease (interleukin-1β conservertase) protects mice against challenge with heterologous group A streptococci Microb Pathog 16 1994 443 450
20. H.S. Courtney, D.L. Hasty, and J.B. Dale Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci Infect Immun 71 9 2003 5097 5103
21. H.S. Courtney, D.L. Hasty, Y. Li, H.C. Chiang, J.L. Thacker, and J.B. Dale Serum opacity factor is a major fibronectin-binding protein and a virulence determinant of M type 2 Streptococcus pyogenes Mol Microbiol 32 1 1999 89 98
22. G.A. Saravani, and D.R. Martin Opacity factor from group A streptococci is an apoproteinase FEMS Microbiol Lett 56 1 1990 35 39
23. A.M. Goodfellow, M. Hibble, S.R. Talay, B. Kreikemeyer, B.J. Currie, and K.S. Sriprakash Distribution and antigenicity of fibronectin binding proteins (SfbI and SfbII) of Streptococcus pyogenes clinical isolates from the Northern Territory, Australia J Clin Microbiol 38 1 2000 389 392
24. C.A. Guzman, S.R. Talay, G. Molinari, E. Medina, and G.S. Chhatwal Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI J Infect Dis 179 4 1999 901 906
25. E. Medina, S.R. Talay, G.S. Chhatwal, and C.A. Guzman Fibronectin-binding protein I of Streptococcus pyogenes promotes T cell-independent proliferation of murine B lymphocytes and enhances the expression of MHC class II molecules on antigen-presenting cells Int Immunol 10 11 1998 1657 1664
26. K. Schulze, E. Medina, G.S. Chhatwal, and C.A. Guzman Identification of B- and T-cell epitopes within the fibronectin-binding domain of the SfbI protein of Streptococcus pyogenes Infect Immun 71 12 2003 7197 7201
27. K. Schulze, E. Medina, G.S. Chhatwal, and C.A. Guzman Stimulation of long-lasting protection against Streptococcus pyogenes after intranasal vaccination with non adjuvanted fibronectin-binding domain of the SfbI protein Vaccine 21 17/18 2003 958 964
28. S.R. Talay, A. Zock, M. Rohde, G. Molinari, M. Oggioni, and G. Pozzi Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells Cell Microbiol 2 6 2000 521 535
29. B. Kreikemeyer, D.R. Martin, and G.S. Chhatwal SfbII protein, a fibronectin binding surface protein of group A streptococci, is a serum opacity factor with high serotype-specific apolipoproteinase activity FEMS Microbiol Lett 178 2 1999 305 311
30. K. Schulze, and C.A. Guzman Identification of the domains of the fibronectin-binding protein I of Streptococcus pyogenes responsible for adjuvanticity FEMS Immunol Med Microbiol 37 2 2003 July 15 173 177
31. E. Medina, S.R. Talay, G.S. Chhatwal, and C.A. Guzman Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route Eur J Immunol 28 3 1998 1069 1077
32. K. Schulze, E. Medina, S.R. Talay, R.J. Towers, G.S. Chhatwal, and C.A. Guzman Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response Infect Immun 69 1 2001 Jan 1 622 625
33. J. McArthur, E. Medina, A. Mueller, J. Chin, B.J. Currie, and K.S. Sriprakash Intranasal vaccination with streptococcal fibronectin binding protein Sfb1 fails to prevent growth and dissemination of Streptococcus pyogenes in a murine skin infection model Infect Immun 72 12 2004 7342 7345
34. G.L. Darmstadt, L. Mentele, A. Podbielski, and C.E. Rubens Role of Group A streptococcal virulence factors in adherence to keratinocytes Infect Immun 68 3 2000 1215 1221